Drug
MK0777
MK0777 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph phase_2
5
100%
Phase Distribution
0
Early Stage
5
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
5(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 25 (100.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)
NCT00543920
completedphase_2
GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)
NCT00546624
completedphase_2
A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)
NCT00703833
completedphase_2
Treatment of Patients With Anxiety Disorder (0777-022)
NCT00539578
completedphase_2
Treatment Study for Cognitive Deficits in Schizophrenia
NCT00505076
Clinical Trials (5)
Showing 5 of 5 trials
NCT00543920Phase 2
A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)
NCT00546624Phase 2
GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)
NCT00703833Phase 2
A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)
NCT00539578Phase 2
Treatment of Patients With Anxiety Disorder (0777-022)
NCT00505076Phase 2
Treatment Study for Cognitive Deficits in Schizophrenia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5